CD8A and neoplasm: In multiple murine models, genetic manipulation of CD38 on the tumor cells, or treatment with either small molecule inhibitors or an anti-CD38 antibody, regulated tumor growth in a CD8 T cell-dependent fashion and produced a broader anti-tumor immune profile.